Glimepiride, Metformin, and Pioglitazone Tablets

GLIMASE MP 2 Tablets contain 2mg of Glimepiride, 500mg of Metformin, and 15mg of Pioglitazone. It is a triple-combination antidiabetic medicine that is used for the management of Type 2 Diabetes Mellitus under the guidance of a qualified healthcare professional.  

For PCD pharma franchise partners, pharmaceutical distributors, wholesalers, medical representatives, and new pharma entrepreneurs, GLIMASE MP2 can be a useful addition to a diabetes medicine product portfolio. It combines three established oral antidiabetic agents in a single tablet, which makes it suitable for businesses that are looking to expand their diabetic care product range. 

Product Highlights:

• Brand Name: GLIMASE MP 2
• Composition: Glimepiride 2 mg + Metformin 500 mg + Pioglitazone 15 mg
• Dosage Form: Tablets
• Therapeutic Segment: Antidiabetic / Diabetes Care
• Pack Size: 10 × 10 Tablets
• Business Category: PCD Pharma / Pharmaceutical Distribution

Glimepiride, Metformin, and Pioglitazone Tablets PCD Pharma Franchise Opportunity – Godase Healthcare

Godase Healthcare offers PCD pharma franchise opportunities for Glimepiride, Metformin, and Pioglitazone Tablets under its own brand name, GLIMASE MP 2, across India. This triple-combination antidiabetic formulation can be included in a diabetes-focused product range. Adding this tablet allows franchise partners to offer a combination formulation along with other antidiabetic and diabetes care medicines in their territory.

Entrepreneurs who are looking to enter or expand in the PCD pharma franchise business can consider Glimepiride, Metformin, and Pioglitazone Tablets as part of a broader antidiabetic product portfolio. All franchise opportunities, monopoly rights, product availability, and commercial terms are subject to territory availability and applicable business conditions.

Why Add GLIMASE MP 2?

Diabetes-care medicines are an important part of a complete pharmaceutical product portfolio. For franchise partners and entrepreneurs, adding different antidiabetic formulations can help to expand their product range. GLIMASE MP 2 tablet contains three active ingredients:

• Glimepiride 2 mg: Helps the pancreas release insulin.
• Metformin 500 mg: Helps reduce glucose production by the liver and supports better insulin sensitivity.
• Pioglitazone 15 mg: Helps improve the body's sensitivity to insulin.

With this triple combination formulation, GLIMASE MP can be added to a diabetes-care and antidiabetic product portfolio.

Business Benefits of GLIMASE MP 2

• 3-in-1 Diabetes Product: Combines Glimepiride, Metformin & Pioglitazone in one formulation.
• Strong Portfolio Addition: Add GLIMASE MP 2 to your diabetes-care product range.
• Established Segment: Antidiabetic medicines are an important pharmaceutical category.
• PCD Business Support: Get marketing, promotional and product support from Godase Healthcare.
• Business Growth Opportunity: Suitable for PCD partners, distributors and new pharma entrepreneurs looking to expand their portfolio.

Disclaimer: GLIMASE MP 2 Tablet is a prescription medicine. The information on this page is for general product and business purposes only and is not medical advice or a prescription. Use the product only under a healthcare professional’s guidance.